Your browser doesn't support javascript.
loading
Unexpectedly high mutation rate of cyp11b1 compared to cyp21a2 in randomly-selected turkish women: a large screening study.
Polat, S; Karaburgu, S; Unluhizarci, K; Dundar, M; Ozkul, Y; Arslan, Y K; Karaca, Z; Kelestimur, F.
Afiliação
  • Polat S; Department of Medical Genetics, Medical Faculty, Erzincan Binali Yildirim University, Basbaglar Mah., 24100, Erzincan, Merkez, Turkey. polatdna@yahoo.com.
  • Karaburgu S; Department of Endocrinology, Medical Faculty, Erciyes University, Kayseri, Turkey.
  • Unluhizarci K; Department of Endocrinology, Medical Faculty, Erciyes University, Kayseri, Turkey.
  • Dundar M; Department of Medical Genetics, Medical Faculty, Erciyes University, Kayseri, Turkey.
  • Ozkul Y; Department of Medical Genetics, Medical Faculty, Erciyes University, Kayseri, Turkey.
  • Arslan YK; Department of Biostatistics, Medical Faculty, Çukurova University, Adana, Turkey.
  • Karaca Z; Department of Endocrinology, Medical Faculty, Erciyes University, Kayseri, Turkey.
  • Kelestimur F; Department of Endocrinology, Medical Faculty, Erciyes University, Kayseri, Turkey.
J Endocrinol Invest ; 46(11): 2367-2377, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37055708
ABSTRACT

PURPOSE:

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders resulting from enzyme deficiencies associated with steroidogenesis. The clinical presentation of non-classic CAH (NCAH) in females is often indistinguishable from other hyperandrogenic disorders like polycystic ovary syndrome (PCOS). The data on the prevalence of NCAH in unselected women in the literature is scanty. The research aimed to evaluate the prevalence of NCAH, carrier frequencies, and the correlation between clinical symptoms and genotype in Turkish women.

METHODS:

The study group comprised two hundred and seventy randomly-selected unrelated asymptomatic women of reproductive age (18-45). Subjects were recruited from female blood donors. All volunteers underwent clinical examination and hormone measurements. The protein-encoding exons and exon-intron boundaries of the CYP21A2, CYP11B1, HSD3ß2 and CYP21A2 promoter were sequenced by direct DNA sequencing.

RESULTS:

After genotyping, seven (2.2%) individuals were diagnosed with NCAH. The heterozygous carrier frequencies of CYP21A2, CYP21A2 promoter, CYP11B1, and HSD3ß2 genes with 34, 34, 41, and 1 pathologic mutation were determined at 12.6%, 12.6%, 15.2%, and 0.37% of volunteers, respectively. Gene-conversion (GC) frequencies between CYP21A2/CYP21A1P and CYP11B1/CYP11B2 were determined as 10.4% and 14.8%, respectively.

CONCLUSION:

Despite GC-derived higher mutation frequency determined in the CYP11B1 gene, the reason for the low frequency of NCAH due to 11OHD compared to 21OHD might be that gene-conversion arises with active CYP11B2 rather than an inactive pseudogene. HSD3ß1 exhibits high homology with HSD3ß2 located on the same chromosome; remarkably, it demonstrates low heterozygosity and no GC, most probably the outcome of a tissue-specific expression pattern.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esteroide 11-beta-Hidroxilase / Hiperplasia Suprarrenal Congênita Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esteroide 11-beta-Hidroxilase / Hiperplasia Suprarrenal Congênita Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article